Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

ProQR Therapeutics N.V (PRQR) Return on Sales: 2021-2025

Historic Return on Sales for ProQR Therapeutics N.V (PRQR) over the last 4 years, with Sep 2025 value amounting to -2.77%.

  • ProQR Therapeutics N.V's Return on Sales fell 141.00% to -2.77% in Q3 2025 from the same period last year, while for Sep 2025 it was -2.77%, marking a year-over-year decrease of 141.00%. This contributed to the annual value of -1.47% for FY2024, which is 279.00% up from last year.
  • ProQR Therapeutics N.V's Return on Sales amounted to -2.77% in Q3 2025, which was down 14.62% from -2.41% recorded in Q2 2025.
  • ProQR Therapeutics N.V's Return on Sales' 5-year high stood at -1.35% during Q3 2024, with a 5-year trough of -36.96% in Q4 2021.
  • Moreover, its 3-year median value for Return on Sales was -2.59% (2024), whereas its average is -5.54%.
  • Its Return on Sales has fluctuated over the past 5 years, first soared by 1,935bps in 2022, then plummeted by 141bps in 2025.
  • Over the past 5 years, ProQR Therapeutics N.V's Return on Sales (Quarterly) stood at -36.96% in 2021, then spiked by 1,935bps to -17.61% in 2022, then skyrocketed by 1,334bps to -4.27% in 2023, then skyrocketed by 279bps to -1.48% in 2024, then crashed by 141bps to -2.77% in 2025.
  • Its Return on Sales was -2.77% in Q3 2025, compared to -2.41% in Q2 2025 and -1.60% in Q1 2025.